Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $52.57 | $41.88 | 25.52% | 131.43x | 13.25x | 14.03x | 6.03x | 0.47x | $46.73M | 1.75% | $450.12M | 8.86 | $2.70B | 93.01 | ||
| GYRE | GYRE THERAPEUTICS INC | $8.02 | $4.50 | 78.26% | 133.67x | -24.57x | 6.15x | 7.33x | 0.69x | -$150.00k | -0.02% | $106.03M | 1.19 | $741.52M | 57.75 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.32 | $18.93 | -45.49% | 7.37x | 20.81x | 5.36x | 3.92x | 0.33x | -$1.99M | -0.35% | $154.66M | 2.80 | $606.70M | 6.11 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $333.39 | $80.83 | 312.45% | 139.49x | 48.84x | 11.76x | 56.03x | 1.76x | $465.38M | 1.07% | $789.18M | 6.02 | $45.53B | 72.10 | ||
| ADMA | ADMA BIOLOGICS INC | $10.65 | $11.81 | -9.82% | 17.18x | 10.93x | 4.97x | 5.31x | 0.46x | $27.82M | 1.10% | $477.32M | 2.00 | $2.52B | 12.75 | ||
| CORT | CORCEPT THERAPEUTICS INC | $43.90 | $20.97 | 109.33% | 46.21x | 80.91x | 5.99x | 7.21x | 1.00x | $141.79M | 3.11% | $647.81M | 6.24 | $4.56B | 100.77 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.05 | $71.28 | -4.54% | 25.78x | 8.32x | 5.84x | 164.52x | 0.43x | $644.59M | 7.90% | $48.81M | 0.41 | $10.04B | 17.52 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $45.89 | $16.42 | 179.43% | 57.36x | 41.60x | 5.03x | 6.19x | 1.37x | $136.42M | 4.01% | $567.61M | 7.65 | $3.36B | 35.67 | ||
| KRYS | KRYSTAL BIOTECH INC | $268.54 | $110.30 | 143.47% | 37.93x | 34.49x | 19.97x | 6.44x | 1.35x | $189.35M | 2.44% | $1.22B | 42.14 | $7.36B | 37.56 | ||
| RPRX | ROYALTY PHARMA PLC | $48.70 | $42.35 | 15.00% | 27.21x | 9.42x | 8.80x | 2.89x | 0.54x | $2.22B | 10.60% | $9.71B | 22.60 | $36.43B | 33.77 | ||
| VCEL | VERICEL CORP | $35.37 | $8.59 | 311.84% | 107.18x | 80.17x | 6.44x | 5.06x | 1.87x | $24.75M | 1.39% | $354.64M | 7.05 | $1.79B | 51.34 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.74 | $3.40 | 39.39% | 21.55x | 17.05x | 2.90x | 4.96x | 0.78x | $13.21M | 3.52% | $76.53M | 0.97 | $317.61M | 16.17 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.22 | $36.66 | -20.29% | 10.59x | 7.96x | 1.93x | 1.94x | 0.49x | $347.89M | 20.71% | $870.22M | 15.14 | $1.10B | 4.32 | ||
| TECH | BIO-TECHNE CORP | $58.49 | $15.80 | 270.28% | 112.48x | 28.92x | 7.50x | 4.55x | 1.62x | $223.02M | 2.45% | $2.01B | 12.90 | $9.33B | 41.20 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.27 | $47.85 | 15.51% | 30.37x | 12.64x | 3.29x | 1.75x | 0.52x | $724.96M | 6.84% | $6.09B | 31.74 | $9.92B | 17.31 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $40.85 | $5.14 | 694.57% | 226.92x | -34.62x | 5.13x | 14.11x | 3.52x | $45.01M | 0.87% | $370.15M | 2.93 | $5.23B | 74.69 | ||
| MNKD | MANNKIND CORP | $2.77 | $1.09 | 154.51% | 138.50x | 318.39x | 2.43x | -16.73x | 1.01x | $13.69M | 1.62% | -$51.02M | -0.17 | $1.38B | 26.14 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $225.09 | $111.26 | 102.31% | 34.95x | 23.48x | 16.24x | 4.41x | 1.07x | $48.09M | 1.10% | $1.02B | 52.60 | $4.77B | 23.90 | ||
| EXEL | EXELIXIS INC | $44.28 | $35.82 | 23.61% | 15.38x | 13.86x | 5.18x | 5.32x | 0.80x | $875.84M | 7.28% | $2.16B | 7.96 | $11.19B | 11.25 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $441.70 | $189.63 | 132.93% | 28.57x | 22.68x | 9.41x | 6.01x | 1.53x | $3.19B | 2.83% | $18.67B | 73.00 | $108.97B | 22.39 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $25.85 | $15.12 | 71.01% | 14.77x | 13.48x | 5.37x | 3.31x | 1.73x | $208.61M | 6.60% | $954.27M | 7.80 | $2.45B | 7.62 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $753.93 | $447.32 | 68.54% | 17.50x | 16.08x | 5.50x | 2.55x | 1.30x | $4.08B | 5.17% | $31.26B | 298.82 | $79.29B | 13.63 | ||
| INCY | INCYTE CORP | $97.10 | $68.98 | 40.76% | 14.73x | 12.55x | 3.69x | 3.74x | 1.08x | $1.35B | 7.15% | $5.17B | 26.47 | $16.26B | 9.24 | ||
| UTHR | UNITED THERAPEUTICS CORP | $577.58 | $271.91 | 112.41% | 19.17x | 19.76x | 8.04x | 3.57x | 1.99x | $1.04B | 4.07% | $7.10B | 160.19 | $23.76B | 13.06 | ||
| VCYT | VERACYTE INC | $34.04 | $10.43 | 226.48% | 40.52x | 32.11x | 5.17x | 2.07x | 2.12x | $126.63M | 4.73% | $1.31B | 16.67 | $2.38B | 25.70 | ||
| XOMA | XOMA ROYALTY CORP | $40.13 | $10.16 | 294.90% | 26.23x | 81.96x | 9.30x | 5.69x | 8.92x | -$1.83M | -0.38% | $83.94M | 6.95 | $520.98M | 15.02 | ||
| MDXG | MIMEDX GROUP INC | $3.88 | $1.91 | 103.50% | 11.76x | 34.58x | 1.37x | 2.25x | 22.75x | $72.97M | 12.73% | $256.55M | 1.74 | $428.28M | 5.39 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.48 | $3.97 | 88.52% | 12.06x | 18.33x | 1.64x | 2.92x | 5.34x | $41.73M | 11.15% | $130.34M | 2.61 | $377.38M | 7.07 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.